Bone & Joint Health Supplements Market

Bone & Joint Health Supplements Market by Type (Vitamin D, Vitamin K, Calcium, Collagen, Omega 3-Fatty Acid, Glucosamine-Chondroitin), Distribution Channels, Form (Tablets, Capsules, Liquid, Powder), Target Consumers and Region - Global Forecast to 2027

Report Code: FB 8121 Jun, 2022, by marketsandmarkets.com

[248 Pages Report] The global bone and joint health supplements market is estimated to be valued at USD 11.7 billion in 2022. It is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period. The global market is expected to grow due to the growing demand for nutritional supplements such as vitamin D, calcium etc. Several innovations in the nutritional supplements sector have been fueling the demand for bone & joint health supplements, and manufacturers have been exploring the multifunctional properties of these products. Technological advancements have also helped widen the application of bone & joint health supplements across different industries.

Bone and Joint Health Supplements Market

To know about the assumptions considered for the study, Request for Free Sample Report

Market Dynamics

Drivers: Aging population to drive the market growth

The elderly population is focusing on adapting to nutritional supplements specifically tailored to their needs to maintain their good health and quality of life. The process of aging results in various changes in individuals, including psychological, physiological, and social, which affect their dietary and food choices. The aging population increasingly relies on habitual food choices and tailored dietary consumption patterns. The rising aging population in some countries, over the years, has increased the demand for developing age-friendly food alternatives with enhanced nutritional value to support their overall health, which has led to an increased demand for bone & joint health supplements that further support the market growth. Consumers have become more aware of healthy aging and disease prevention with increasing bone health and mobility concerns. Thus, there is an increased demand for supplemental nutrition solutions that align with the nutritional needs of aging consumers.

Restraints: High R & D investments and high cost of clinical trials

Nutraceutical products such as bone & joint health supplements are clinically and chemically developed and hence, require extensive R&D investments, clinical trials, and approvals from respective authorities in different countries/regions. Besides, developing such products is not a short-term activity, as it includes the formulation, trial & testing, and commercialization of it into the market. However, high R&D investments do not give equal returns in terms of productivity, as even after successful molecule discovery, the cost of bringing a new supplement into the market is significantly high. The cost of proving the effectiveness of a bone & joint health supplement through clinical trials is also relatively expensive. It can be a major hindrance to developing novel supplements in the market.

Opportunities: Consumer awareness about micronutrient deficiencies

Consumers are becoming increasingly aware of the risks and prevalence of nutritional deficiencies. Also, their knowledge about how nutritional deficiencies can be optimized through supplementation will drive increased intake of bone & joint health supplements further driving the market growth. The link between diet and health is significant, and people are opting for healthier supplement alternatives. The rising middle-class income in parts of Asia, Latin America, and Africa has enabled consumers to spend more on nutritional, dietary, and food supplements. The growth in the world’s older population in parts of Europe and other regions is likely to be more aware of nutritional deficiencies, thereby driving the demand for dietary supplements. In 2013, according to the Business Development Bank of Canada, “health concerns are rising, and health awareness is growing among Canadian consumers and will continue to accelerate as the population ages, with 25% of the population over the age of 65 by 2031.

Challenges: Regulatory influence

The overall shift in consumer trends is causing several changes in the bone & joint health supplements market. There are changing regulations and mandates regarding nutrition through dietary supplements. Changing standards of nutritional care have led to the formulation of these regulations. Some of these regulations are introduced by the FDA and FSSAI. These regulations cover health supplements, food for special dietary use, and probiotic and prebiotic foods. There are recommended dietary allowances and safe upper limits recognized by the Food and Nutrition Board of the National Academy of Medicine. There are regulatory challenges related to the safety, quality, and effectiveness of bone & joint health supplements. Regulations regarding vitamins-based and omega fatty acids-based supplements offered in South Africa ensure that all the products are registered and evaluated under SAHPRA. These new regulations can pose significant challenges for the overall market.

The tablet segment is estimated to grow at the highest CAGR during the forecast period

The tablet form of bone & joint health supplements is widely consumed on account of the easy availability of various dosage patterns, easy packaging techniques, storage, and cost-effectiveness. Bone & joint health supplements in the tablet form are consumed for various nutrients such as vitamins and omega-3 fatty acids enclosed in it. Tablets are also preferred in comparison to other types of nutritional supplements due to the high shelf life associated with them. Compressed tablets have the advantage of being generally stable and available in a variety of sizes and shapes. As a result, a wide range of nutritional supplements can be easily incorporated into tablet form. For this reason, compressed tablets are popular.

The supermarket/hypermarket segment is estimated to account for the largest share in the market in 2022

Supermarkets expanded the scope of traditional smaller grocers and general stores to cover products such as health supplements decades ago, and so also represent a small but firmly established sales channel for health food market. Interestingly, unlike Pharmacies, products bought at supermarkets are mostly intended for use by someone other than the consumer, but as gifts, or bought for a family member. Developed countries from North America and Europe are expecting a major growth compared to developing countries because of there is more awareness of health supplements buying criteria though in developing countries people are used by a health supplement from pharmacies only.

Bone & Joint Health Supplements Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America dominated the bone & joint health supplements market, with a value of USD 3,736.6 million in 2021; it is projected to reach USD 5,873.9 million by 2027, at a CAGR of 7.9% during the forecast period.

North America is one of the major consumers of bone & joint health supplements globally, owing to the high demand from elderly people population. Due to this, a few leading bone & joint health supplements manufacturers are established across this region, such as Procter & Gamble (US), Amway (US), Archer Daniels Midland (US), Reckitt Benckiser (UK), Pfizer (US), Arazo Nutrition (US), Nature’s Sunshine Products, Inc (US). Increasing aging population in the Asia Pacific region in countries such as Japan, China and India which are witnessing the higher growth in future for bone & joint health supplements. Hence, in terms of growth, it is expected that the Asia Pacific region would be growing at the highest rate, driven by the increasing awareness of bone & joint health with increasing aging population.

Key Market Players

The key players in this market include Bayer AG(Germany), Procter & Gamble (US), Amway (US), Basf SE (Germany) and Archer Daniels Midland (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2022–2027

Base year considered

2021

Forecast period considered

2022–2027

Units considered

Value (USD)

Segments covered

 

By type, distribution channel, form, target consumer and region

Regions covered

North America, Asia Pacific, Europe, South America and RoW

Companies studied

  • Bayer AG(Germany)
  • Procter & Gamble (US)
  • Amway (US)
  • BASF SE (Germany)
  • Archer Daniels Midland (US)
  • Reckitt Benckiser (UK)
  • Pfizer (US)
  • Vita Life Sciences Ltd (Australia)
  • Arazo Nutrition (US)
  • Nature’s Sunshine Products, Inc (US)
  • (France)
  • Glanbia Plc (Ireland)
  • Vitawin(India)
  • Nutramax Laboratories Consumer Care, Inc(US)
  • Simply Supplements(UK)
  • Love Life Supplements(UK)
  • Now Foods(US)
  • Bellavita Healthcare Pvt Ltd(India)
  • Vitaco(New Zealand)
  • Nutravita(UK)
  • Life Extension(US)
  • Pure Encapsulations, LLC (US)
  • Herbs Nutriproducts Pvt. Ltd. (India)
  • Millennium Herbal Care (India)

This research report categorizes the Bone & Joint Health Supplement Market, based on type, distribution channel, form, target consumer and region

Target Audience:

  • Manufacturers of food products, beverages, and bone & joint health supplements
  • Manufacturers of nutraceutical ingredients
  • Intermediary suppliers, such as traders and distributors of nutraceutical products
  • Government and research organizations
  • Associations, regulatory bodies, and other industry-related bodies:
  • Food and Agriculture Organization (FAO)
  • United States Department of Agriculture (USDA)
  • Food Safety Council (FSC)
  • Food and Drug Administration (FDA)
  • European Food Safety Authority (EFSA)
  • Food Standards Australia New Zealand (FSANZ)
  • Dietary Supplement Health and Education Act (DSHEA)
  • International Probiotics Association
  • Indian Health Foods and Dietary Supplements Association (INHADSA)

Report Scope:

By Type

  • Vitamin D
  • Vitamin K
  • Calcium
  • Collagen
  • Omega-3 Fatty acids
  • Glucosamine-Chondroitin
  • Others

By Distribution channels

  • Supermarkets/hypermarkets
  • Pharmacies & drug stores
  • Health & beauty stores
  • Others

By Form:

  • Tablets
  • Capsules
  • Liquid
  • Powder
  • Others

By Target consumers:

  • Infants
  • Children
  • Adults
  • Pregnant woman
  • Elderly people

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Rest of the World (RoW)

Recent Developments

  • In February 2022, Amway has launched jelly strips under its flagship brand Nutrilite.
  • In December 2021, ADM acquired Flavor Infusion International(FISA), a full range provider of flavor and specialty ingredients across Latin America and the Caribbean.
  • In November 2021, Nature’s Bounty has launched jelly beans vitamins that cater to a variety of wellness needs.
  • In November 2020, Bayer acquired a majority stake in Care/of which manufactures high quality vitamins, supplements and powders.
  • In August 2019, Herbs Nutriproducts Pvt. Ltd. has opened Pure Nutrition brand store at Delhi airport. The store has a wide range of products including bone and joint health supplements.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
           1.3.1 INCLUSIONS AND EXCLUSIONS
    1.4 REGIONS COVERED
    1.5 PERIODIZATION CONSIDERED
    1.6 CURRENCY CONSIDERED
    1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION
           2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
    2.4 ASSUMPTIONS FOR THE STUDY
    2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS

3 EXECUTIVE SUMMARY (Page No. - 41)

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 ATTRACTIVE GROWTH OPPORTUNITIES IN THE BONE &  JOINT HEALTH SUPPLEMENTS MARKET
    4.2 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENT MARKET,  BY TYPE & COUNTRY
    4.3 BONE & JOINT HEALTH SUPPLEMENT MARKET,  BY TARGET CONSUMERS
    4.4 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY FORM AND  BY REGION
    4.5 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY REGION

5 MARKET OVERVIEW (Page No. - 49)
    5.1 INTRODUCTION
    5.2 MACROECONOMIC INDICATORS
           5.2.1 AGING POPULATION
           5.2.2 GLOBAL POPULATION IS WITNESSING A HIGH PROPORTION OF OBESITY
           5.2.3 KEY FACTS
    5.3 MARKET DYNAMICS
           5.3.1 DRIVERS
                    5.3.1.1 Increase in the prevalence of vitamin D deficiencies across the globe is expected to boost demand
                    5.3.1.2 Shift in consumer preferences due to the rising health awareness
                    5.3.1.3 Aging population to drive the market growth
                    5.3.1.4 Growing retail sale of nutritional & fortified products
           5.3.2 RESTRAINTS
                    5.3.2.1 High R&D investments and high cost of clinical trials
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Rise in the number of osteoporosis patients is anticipated to propel the market demand
                    5.3.3.2 Food fortification to satisfy consumer awareness about micronutrient deficiencies
           5.3.4 CHALLENGES
                    5.3.4.1 Consumer skepticism associated with nutraceutical products
                    5.3.4.2 Regulatory influence

6 INDUSTRY TRENDS (Page No. - 58)
    6.1 OVERVIEW
    6.2 REGULATORY FRAMEWORK
           6.2.1 NORTH AMERICA
                    6.2.1.1 Canada
                    6.2.1.2 US
                    6.2.1.3 Mexico
           6.2.2 EUROPEAN UNION
           6.2.3 ASIA PACIFIC
                    6.2.3.1 Japan
                    6.2.3.2 China
                    6.2.3.3 India
                    6.2.3.4 Australia & New Zealand
           6.2.4 SOUTH AMERICA
                    6.2.4.1 Brazil
                    6.2.4.2 Argentina
           6.2.5 MIDDLE EAST
    6.3 REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
    6.4 TRADE ANALYSIS
    6.5 PATENT ANALYSIS
    6.6 VALUE CHAIN ANALYSIS
           6.6.1 RESEARCH & DEVELOPMENT
           6.6.2 MANUFACTURING
           6.6.3 PACKAGING AND STORAGE
           6.6.4 DISTRIBUTION
           6.6.5 END USER
    6.7 TRENDS/DISRUPTIONS IMPACTING THE CUSTOMER’S BUSINESS
    6.8 ECOSYSTEM/MARKET MAP
           6.8.1 MARKET MAP
    6.9 TECHNOLOGY ANALYSIS
           6.9.1 FOOD MICROENCAPSULATION
                    6.9.1.1 Encapsulation of Omega-3 to mask the odor
           6.9.2 BIOTECHNOLOGY
           6.9.3 INNOVATIVE AND DISRUPTIVE TECH
                    6.9.3.1 Robotics as a key technological trend leading to innovations in the market
                    6.9.3.2 3D printing to uplift the future of the dietary supplements market with high end products
                    6.9.3.3 Hologram Sciences: Consumer-facing digital platforms for personalized nutrition and advice
    6.10 PORTER’S FIVE FORCES ANALYSIS
           6.10.1 DEGREE OF COMPETITION
           6.10.2 BARGAINING POWER OF SUPPLIERS
           6.10.3 BARGAINING POWER OF BUYERS
           6.10.4 THREAT OF SUBSTITUTES
           6.10.5 THREAT OF NEW ENTRANTS
    6.11 KEY CONFERENCES & EVENTS IN 2022-2023
    6.12 KEY STAKEHOLDERS & BUYING CRITERIA
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
           6.12.2 BUYING CRITERIA
    6.13 CASE STUDY ANALYSIS
           6.13.1 SAFETY ASSESSMENT AND CERTIFICATION DEMAND BY INDUSTRY PLAYERS TO ENSURE TRANSPARENCY
                    6.13.1.1 Problem statement
                    6.13.1.2 Solution offered
                    6.13.1.3 Outcome
           6.13.2 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
                    6.13.2.1 Problem statement
                    6.13.2.2 Solution offered
                    6.13.2.3 Outcome
           6.13.3 NOW FOODS AVAILS FLAVOURED DIETARY SUPPLEMENT PRODUCTS
                    6.13.3.1 Problem statement
                    6.13.3.2 Solution offered
                    6.13.3.3 Outcome
           6.13.4 BAYER AG: HOW CAN WE MAKE OUR EXTENDED LIFESPAN A HEALTHY ONE?
                    6.13.4.1 Problem statement
                    6.13.4.2 Solution offered
                    6.13.4.3 Outcome
    6.14 AVERAGE SELLING PRICES

7 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE (Page No. - 90)
    7.1 INTRODUCTION
    7.2 VITAMIN D
           7.2.1 DEFICIENCY OF VITAMIN D IS THE KEY FACTOR DRIVING THEIR USAGE
    7.3 VITAMIN K
           7.3.1 VITAMIN K PLAYS A VITAL ROLE IN BONE HEALTH
    7.4 CALCIUM
           7.4.1 LACTOSE INTOLERANCE PEOPLE DRIVING THE GROWTH OF CALCIUM SUPPLEMENTS
    7.5 COLLAGEN
           7.5.1 RISE IN THE AGING POPLUATION IN DEVELOPED COUNTRIES CONTRIBUTES TO HIGHER GROWTH OF THE COLLAGEN MARKET IN FUTURE
    7.6 OMEGA 3 FATTY ACID
           7.6.1 OMEGA 3 FATTY ACIDS HAVE ANTI-INFLAMMATORY EFFECTS
    7.7 GLUCOSAMINE AND CHONDROITIN
           7.7.1 HEALTH-CONSCIOUS PEOPLE ARE TAKING GLUCOSAMINE AND CHONDROITIN AS A PREVENTIVE MEASURE AGAINST ARTHRITIS
    7.8 OTHER TYPES
           7.8.1 VEGAN AND VEGETARIAN PEOPLE ARE DRIVING THE DEMAND FOR PLANT BASED SUPPLEMENTS

8 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY FORM (Page No. - 101)
    8.1 INTRODUCTION
    8.2 TABLETS
           8.2.1 LONG LIFE IS THE KEY TO THE GROWTH OF THE TABLET FORM OF BONE & JOINT HEALTH SUPPLEMENTS
    8.3 CAPSULES
           8.3.1 FASTER ABSORPTION OF NUTRIENTS THROUGH CAPSULES
    8.4 LIQUID
           8.4.1 HIGH ABSORPTION OF LIQUIDS UPON CONSUMPTION IS EXPECTED TO PROPEL THE MARKET GROWTH OF LIQUID SUPPLEMENTS
    8.5 POWDER
           8.5.1 EASY RELEASE OF ACTIVE INGREDIENTS DRIVING THE USAGE OF THE POWDER FORM
    8.6 OTHER FORMS
           8.6.1 RELATIVELY LOW-COST DRIVING DEMAND OF OTHER SEGMENT

9 BONE & JOINT HEALTH SUPPLEMENTS MARKET,  BY TARGET CONSUMER (Page No. - 114)
    9.1 INTRODUCTION
    9.2 INFANTS
           9.2.1 ESSENTIAL NUTRIENTS REQUIRED FOR INFANT NUTRITION TRIGGER THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
    9.3 CHILDREN
           9.3.1 RISE IN CONSUMPTION OF NUTRIENTS AMONG CHILDREN PROPELLING THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
    9.4 ADULTS
           9.4.1 DEFICIENCY OF SEVERAL MINERALS AND VITAMINS IN ADULTS
    9.5 PREGNANT WOMEN
           9.5.1 REQUIREMENT FOR OPTIMAL NUTRITION DURING PREGNANCY DRIVING THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
    9.6 ELDERLY
           9.6.1 NEED FOR CONSUMPTION OF BONE & JOINT HEALTH SUPPLEMENTS BY THE AGING POPULATION

10 BONE & JOINT HEALTH SUPPLEMENTS MARKET,  BY DISTRIBUTION CHANNEL (Page No. - 123)
     10.1 INTRODUCTION
     10.2 SUPERMARKETS/HYPERMARKETS
             10.2.1 SUPERMARKETS OF DEVELOPED COUNTRIES CONTRIBUTE A MAJOR SHARE OF BONE & JOINT HEALTH SUPPLEMENTS
     10.3 PHARMACIES & DRUG STORES
             10.3.1 ELDERLY PEOPLE PREFER PHARMACIES OVER CONVENTIONAL STORE
     10.4 HEALTH AND BEAUTY STORES
             10.4.1 PATIENT-DIRECTED APPROACH DRIVES THE MARKET FOR HEALTH CENTERS, GLOBALLY
     10.5 OTHER DISTRIBUTION CHANNELS
             10.5.1 EASY ACCESSIBILITY TO A WIDE RANGE OF HEALTH PRODUCTS AIDS SALES OF BONE & JOINT HEALTH SUPPLEMENTS

11 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY REGION (Page No. - 130)
     11.1 INTRODUCTION
     11.2 NORTH AMERICA
             11.2.1 US
                       11.2.1.1 Vitamin D deficiency fueling the growth of the market
             11.2.2 CANADA
                       11.2.2.1 Markets for Omega-3 fatty acids, vitamin d, and calcium as bone & joint health supplements gaining an opportunity
             11.2.3 MEXICO
                       11.2.3.1 Malnutrition and obesity triggering the demand for bone & joint health supplements
     11.3 EUROPE
             11.3.1 GERMANY
                       11.3.1.1 Surge in demand for plant-based food products provides an avenue for herbal supplements
             11.3.2 UK
                       11.3.2.1 Increasing risk of arthritis gaining popularity for bone & joint health supplements
             11.3.3 FRANCE
                       11.3.3.1 Government support for promoting the consumption of nutritional supplements
             11.3.4 ITALY
                       11.3.4.1 Higher prevalence of vitamin d deficiency driving the demand for bone & joint health supplements
             11.3.5 SPAIN
                       11.3.5.1 Consumer preference for clean-label ingredients paving the way for bone & joint health supplement products
             11.3.6 REST OF EUROPE
                       11.3.6.1 Rising aging population and growing awareness about the importance of consuming healthy foods
     11.4 ASIA PACIFIC
             11.4.1 CHINA
                       11.4.1.1 Elderly and the millennial population are the forefront users of nutritional supplements for bone & joint health
             11.4.2 INDIA
                       11.4.2.1 The millennial population play a key role in driving the demand for bone & joint health supplements
             11.4.3 JAPAN
                       11.4.3.1 Rise in the aging population is driving the growth of the market
             11.4.4 REST OF ASIA PACIFIC
                       11.4.4.1 Surge in the consumption rate of several types of healthy food products helping the growth of nutritional supplements of bone & joint supplements
     11.5 SOUTH AMERICA
             11.5.1 BRAZIL
                       11.5.1.1 Increasing obesity is driving the consumers toward bone & joint health supplements
             11.5.2 ARGENTINA
                       11.5.2.1 Increase in the osteoporosis concern influencing the growth of bone & joint health supplements
             11.5.3 REST OF SOUTH AMERICA
                       11.5.3.1 Influence of health and wellness trends contributing to the market growth
     11.6 REST OF THE WORLD
             11.6.1 AFRICA
                       11.6.1.1 Prevalence of vitamin deficiency among women and children results in concerning authorities providing food products, including bone & joint health supplements
             11.6.2 MIDDLE EAST
                       11.6.2.1 Use of bone & joint health supplements for the pharmaceuticals and sports nutrition segments

12 COMPETITIVE LANDSCAPE (Page No. - 187)
     12.1 OVERVIEW
     12.2 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS
     12.3 MARKET SHARE ANALYSIS, 2021
     12.4 KEY PLAYER STRATEGIES
     12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
             12.5.1 STARS
             12.5.2 PERVASIVE PLAYERS
             12.5.3 EMERGING LEADERS
             12.5.4 PARTICIPANTS
     12.6 PRODUCT FOOTPRINT
     12.7 START-UP/SME EVALUATION QUADRANT (OTHER PLAYERS)
             12.7.1 PROGRESSIVE COMPANIES
             12.7.2 STARTING BLOCKS
             12.7.3 RESPONSIVE COMPANIES
             12.7.4 DYNAMIC COMPANIES
             12.7.5 NEW PRODUCT LAUNCHES
             12.7.6 DEALS

13 COMPANY PROFILES (Page No. - 199)
     13.1 KEY PLAYERS
             13.1.1 BAYER AG
                       13.1.1.1 Business overview
                       13.1.1.2 Products offered
                       13.1.1.3 Recent developments
                       13.1.1.4 MnM view
                                   13.1.1.4.1 Key strengths/Right to win
                                   13.1.1.4.2 Strategic choices made
                                   13.1.1.4.3 Weaknesses and competitive threats
             13.1.2 PROCTER & GAMBLE
                       13.1.2.1 Business overview
                       13.1.2.2 Products offered
                       13.1.2.3 Recent developments
                       13.1.2.4 MnM view
                                   13.1.2.4.1 Key strengths/Right to win
                                   13.1.2.4.2 Strategic choices made
                                   13.1.2.4.3 Weaknesses and competitive threats
             13.1.3 AMWAY
                       13.1.3.1 Business overview
                       13.1.3.2 Products offered
                       13.1.3.3 Recent developments
                       13.1.3.4 MnM view
                                   13.1.3.4.1 Key strengths/Right to win
                                   13.1.3.4.2 Strategic choices made
                                   13.1.3.4.3 Weaknesses and competitive threats
             13.1.4 BASF SE
                       13.1.4.1 Business Overview
                       13.1.4.2 Products offered
                       13.1.4.3 MnM view
                                   13.1.4.3.1 Key strengths/Right to win
                                   13.1.4.3.2 Strategic choices made
                                   13.1.4.3.3 Weaknesses and competitive threats
             13.1.5 ADM
                       13.1.5.1 Business overview
                       13.1.5.2 Products offered
                       13.1.5.3 MnM view
                                   13.1.5.3.1 Key strengths/Right to win
                                   13.1.5.3.2 Strategic choices made
                                   13.1.5.3.3 Weaknesses and competitive threats
             13.1.6 RECKITT BENCKISER GROUP PLC
                       13.1.6.1 Business overview
                       13.1.6.2 MnM view
                                   13.1.6.2.1 Key strengths/Right to win
                                   13.1.6.2.2 Strategic choices made
                                   13.1.6.2.3 Weaknesses and competitive threats
             13.1.7 PFIZER
                       13.1.7.1 Business overview
                       13.1.7.2 MnM view
                                   13.1.7.2.1 Strengths/Right to win
                                   13.1.7.2.2 Strategic choices made
                                   13.1.7.2.3 Weaknesses and competitive threats
             13.1.8 VITA LIFE SCIENCES
                       13.1.8.1 Business overview
                       13.1.8.2 MnM view
                                   13.1.8.2.1 Strengths/Right to win
                                   13.1.8.2.2 Strategic choices made
                                   13.1.8.2.3 Weaknesses and competitive threats
             13.1.9 NATURE'S SUNSHINE PRODUCTS, INC.
                       13.1.9.1 Business overview
                       13.1.9.2 Products offered
                       13.1.9.3 MnM view
                                   13.1.9.3.1 Key strengths/Right to win
                                   13.1.9.3.2 Strategic choices made
                                   13.1.9.3.3 Weaknesses and competitive threats
               13.1.10 GLANBIA PLC
                          13.1.10.1 Business overview
                          13.1.10.2 Products offered
                          13.1.10.3 MnM view
                     13.1.10.3.1 Key strengths/Right to win
                     13.1.10.3.2 Strategic choices made
                     13.1.10.3.3 Weaknesses and competitive threats
               13.1.11 ARAZO NUTRITION
                          13.1.11.1 Business overview
                          13.1.11.2 MnM view
               13.1.12 NATURE’S BOUNTY
                          13.1.12.1 Business overview
                          13.1.12.2 Products offered
                          13.1.12.3 Recent developments
                          13.1.12.4 MNM View
               13.1.13 BUTTERFLY AYURVEDA PVT. LTD.
                          13.1.13.1 Business overview
                          13.1.13.2 Products offered
                          13.1.13.3 MnM view
               13.1.14 HERBS NUTRIPRODUCTS PVT. LTD.
                         13.1.14.1 Business overview
                         13.1.14.2 Products offered
                         13.1.14.3 Recent developments
                         13.1.14.4 MnM view
               13.1.15 MILLENNIUM HERBAL CARE
                          13.1.15.1 Business overview
                          13.1.15.2 Service offered
                          13.1.15.3 MnM view
     13.2 OTHER PLAYERS
             13.2.1 VITAWIN
             13.2.2 NUTRAMAX LABORATORIES CONSUMER CARE, INC.
             13.2.3 SIMPLY SUPPLEMENTS
             13.2.4 LOVE LIFE SUPPLEMENTS LTD.,
             13.2.5 NOW FOODS
             13.2.6 BELLAVITA HEALTHCARE PRIVATE LIMITED
             13.2.7 VITACO
             13.2.8 NUTRAVITA
             13.2.9 LIFE EXTENSION
             13.2.10 PURE ENCAPSULATIONS, LLC.

14 ADJACENT AND RELATED MARKETS (Page No. - 244)
     14.1 INTRODUCTION
     14.2 LIMITATIONS
     14.3 DIETARY SUPPLEMENTS MARKET
             14.3.1 MARKET DEFINITION
             14.3.2 MARKET OVERVIEW
     14.4 NUTRACEUTICAL PRODUCTS MARKET
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
     14.5 VITAMIN D MARKET
             14.5.1 MARKET DEFINITION
             14.5.2 MARKET OVERVIEW
     14.6 COLLAGEN MARKET
             14.6.1 MARKET DEFINITION
             14.6.2 MARKET OVERVIEW

15 APPENDIX (Page No. - 249)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS


LIST OF TABLES (222 Tables)
 
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017–2021
TABLE 2 BONE & JOINT HEALTH SUPPLEMENTS MARKET SNAPSHOT, 2022 VS. 2027
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
TABLE 5 ASIA-PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
TABLE 6 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
TABLE 8 KEY EXPORTING COUNTRIES WITH EXPORT VALUE OF VITAMINS & VITAMIN SUPPLEMENTS, 2021 (USD MILLION)
TABLE 9 KEY PATENTS PERTAINING TO BONE & JOINT HEALTH SUPPLEMENTS, 2021
TABLE 10 DIETARY SUPPLEMENTRS MARKET: ECOSYSTEM
TABLE 11 BONE & JOINT HEALTH SUPPLEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 BONE AND JOINT HEALTH SUPPLEMENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
TABLE 13 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE FORMS (%)
TABLE 14 KEY BUYING CRITERIA FOR TOP THREE FORMS
TABLE 15 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 16 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 17 VITAMIN D: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 18 VITAMIN D: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 19 VITAMIN K: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 20 VITAMIN K: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 21 CALCIUM: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 22 CALCIUM: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 23 COLLAGEN: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 24 COLLAGEN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 25 OMEGA 3 FATTY ACID: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 26 OMEGA 3 FATTY ACID: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 27 GLUCOSAMINE AND CHONDROITIN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 28 GLUCOSAMINE AND CHONDRAITIN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 29 OTHER TYPES: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 30 OTHER TYPES: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 31 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY FORM,  2017–2021 (USD MILLION)
TABLE 32 MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 33 MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 34 MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 35 TABLETS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 36 TABLETS: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 37 TABLETS: MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 38 TABLETS: MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 39 CAPSULES: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 40 CAPSULES: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 41 CAPSULES: MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 42 CAPSULES:MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 43 LIQUID: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 44 LIQUID: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 45 LIQUID: MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 46 LIQUID: MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 47 POWDER: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 48 POWDER: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 49 POWDER: MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 50 POWDER: MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 51 OTHER FORMS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 52 OTHER FORMS: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 53 OTHER FORMS: MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 54 OTHER FORMS: MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 55 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TARGET CONSUMER,  2017–2021 (USD MILLION)
TABLE 56 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TARGET CONSUMER,  2022–2027 (USD MILLION)
TABLE 57 INFANTS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 58 INFANTS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 59 CHILDREN: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 60 CHILDREN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 61 ADULTS: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION,  2017–2021 (USD MILLION)
TABLE 62 ADULTS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 63 PREGNANT WOMEN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 64 PREGNANT WOMEN: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 65 ELDERLY: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 66 ELDERLY: MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 67 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY DISTRIBUTION CHANNEL,  2017–2021 (USD MILLION)
TABLE 68 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL,  2022–2027 (USD MILLION)
TABLE 69 SUPERMARKETS/HYPERMARKETS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE,  BY REGION, 2017–2021 (USD MILLION)
TABLE 70 SUPERMARKETS/HYPERMARKETS: MARKET SIZE,  BY REGION, 2022–2027 (USD MILLION)
TABLE 71 PHARMACIES & DRUG STORES: BONE & JOINT HEALTH MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 72 PHARMACIES & DRUG STORES: MARKET SIZE,  BY REGION, 2022–2027 (USD MILLION)
TABLE 73 HEALTH & BEAUTY STORES: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE,  BY REGION, 2017–2021 (USD MILLION)
TABLE 74 HEALTH & BEAUTY STORES: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE,  BY REGION, 2022–2027 (USD MILLION)
TABLE 75 OTHER DISTRIBUTION CHANNELS: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 76 OTHER DISTRIBUTION CHANNELS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE,  BY REGION, 2022–2027 (USD MILLION)
TABLE 77 GLOBAL BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION,  2017–2021 (USD MILLION)
TABLE 78 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (USD MILLION)
TABLE 79 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2017–2021 (KILOTONS)
TABLE 80 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION,  2022–2027 (KILOTONS)
TABLE 81 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY,  2017–2021 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET SIZE, BY COUNTRY,  2022–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 84 NORTH AMERICA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET SIZE, BY FORM,  2017–2021 (USD MILLION)
TABLE 86 NORTH AMERICA: MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 88 NORTH AMERICA: MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 89 NORTH AMERICA: MARKET SIZE,  BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET SIZE,  BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 93 US: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 94 US: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 95 CANADA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 96 CANADA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 97 MEXICO: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 98 MEXICO: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 99 EUROPE: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY,  2017–2021 (USD MILLION)
TABLE 100 EUROPE: MARKET SIZE, BY COUNTRY,  2022–2027 (USD MILLION)
TABLE 101 EUROPE: MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 102 EUROPE: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 103 EUROPE: MARKET SIZE, BY FORM,  2017–2021 (USD MILLION)
TABLE 104 EUROPE: MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 105 EUROPE: MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 106 EUROPE: MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 107 EUROPE: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 108 EUROPE: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 109 EUROPE: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 110 EUROPE: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 111 GERMANY: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 112 GERMANY: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 113 UK: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 114 UK: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 115 FRANCE: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 116 FRANCE: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 117 ITALY: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 118 ITALY: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 119 SPAIN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 120 SPAIN: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 121 REST OF EUROPE: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 122 REST OF EUROPE: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY,  2017–2021 (USD MILLION)
TABLE 124 ASIA PACIFIC: MARKET SIZE, BY COUNTRY,  2022–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 126 ASIA PACIFIC: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: MARKET SIZE, BY FORM,  2017–2021 (USD MILLION)
TABLE 128 ASIA PACIFIC: MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 130 ASIA PACIFIC: MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 131 ASIA PACIFIC: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 135 CHINA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 136 CHINA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 137 INDIA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 138 INDIA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 139 JAPAN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 140 JAPAN: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 142 REST OF ASIA PACIFIC: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 143 SOUTH AMERICA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY COUNTRY,  2017–2021 (USD MILLION)
TABLE 144 SOUTH AMERICA: MARKET SIZE, BY COUNTRY,  2022–2027 (USD MILLION)
TABLE 145 SOUTH AMERICA: MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 146 SOUTH AMERICA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 147 SOUTH AMERICA: MARKET SIZE, BY FORM,  2017–2021 (USD MILLION)
TABLE 148 SOUTH AMERICA: MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 149 SOUTH AMERICA: MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 150 SOUTH AMERICA: MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 151 SOUTH AMERICA: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 152 SOUTH AMERICA: MARKET SIZE,  BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 153 SOUTH AMERICA: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 154 SOUTH AMERICA: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 155 BRAZIL: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 156 BRAZIL: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 157 ARGENTINA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE,  2017–2021 (USD MILLION)
TABLE 158 ARGENTINA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 159 REST OF SOUTH AMERICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 160 REST OF SOUTH AMERICA: MARKET SIZE,  BY TYPE, 2022–2027 (USD MILLION)
TABLE 161 REST OF THE WORLD: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 162 REST OF THE WORLD: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 163 REST OF THE WORLD: MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 164 REST OF THE WORLD: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 165 REST OF THE WORLD: MARKET SIZE, BY FORM,  2017–2021 (USD MILLION)
TABLE 166 REST OF THE WORLD: MARKET SIZE, BY FORM,  2022–2027 (USD MILLION)
TABLE 167 REST OF THE WORLD: MARKET SIZE, BY FORM,  2017–2021 (KILOTONS)
TABLE 168 REST OF THE WORLD: MARKET SIZE, BY FORM,  2022–2027 (KILOTONS)
TABLE 169 REST OF THE WORLD: MARKET SIZE,  BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 170 REST OF THE WORLD: MARKET SIZE,  BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 171 REST OF THE WORLD: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 172 REST OF THE WORLD: MARKET SIZE,  BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 173 AFRICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 174 AFRICA: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 175 MIDDLE EAST: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE,  2017–2021 (USD MILLION)
TABLE 176 MIDDLE EAST: MARKET SIZE, BY TYPE,  2022–2027 (USD MILLION)
TABLE 177 BONE & JOINT HEALTH SUPPLEMENT MARKET: DEGREE OF COMPETITION
TABLE 178 COMPANY, BY TYPE FOOTPRINT
TABLE 179 COMPANY, BY APPLICATION FOOTPRINT
TABLE 180 COMPANY, BY REGIONAL FOOTPRINT
TABLE 181 COMPANY, BY OVERALL FOOTPRINT
TABLE 182 DETAILED LIST OF KEY STARTUP/SMES
TABLE 183 BONE & JOINT HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
TABLE 184 BONE & JOINT HEALTH SUPPLEMENTS MARKET: NEW PRODUCT LAUNCHES, 2018–2021
TABLE 185 BONE & JOINT HEALTH SUPPLEMENT MARKET: DEALS, 2018–2021
TABLE 186 BAYER AG: BUSINESS OVERVIEW
TABLE 187 BAYER AG: PRODUCTS OFFERED
TABLE 188 PROCTER & GAMBLE: BUSINESS OVERVIEW
TABLE 189 PROCTER & GAMBLE: PRODUCTS OFFERED
TABLE 190 AMWAY: PRODUCTS OFFERED
TABLE 191 BASF SE: BUSINESS OVERVIEW
TABLE 192 BASF SE: PRODUCTS OFFERED
TABLE 193 ADM: BUSINESS OVERVIEW
TABLE 194 ADM: PRODUCTS OFFERED
TABLE 195 RECKITT BENCKISER GROUP PLC: BUSINESS OVERVIEW
TABLE 196 RECKITT BENCKISER: PRODUCTS OFFERED
TABLE 197 PFIZER: BUSINESS OVERVIEW
TABLE 198 PFIZER: PRODUCTS OFFERED
TABLE 199 VITA LIFE SCIENCES: BUSINESS OVERVIEW
TABLE 200 VITA LIFE SCIENCES: PRODUCTS OFFERED
TABLE 201 NATURE'S SUNSHINE PRODUCTS, INC.: BUSINESS OVERVIEW
TABLE 202 NATURE'S SUNSHINE PRODUCTS, INC.: PRODUCTS OFFERED
TABLE 203 GLANBIA PLC: BUSINESS OVERVIEW
TABLE 204 GLANBIA PLC: PRODUCTS OFFERED
TABLE 205 ARAZO NUTRITION: BUSINESS OVERVIEW
TABLE 206 ARAZO NUTRITION: PRODUCTS OFFERED
TABLE 207 NATURE’S BOUNTY: BUSINESS OVERVIEW
TABLE 208 NATURE’S BOUNTY: PRODUCTS OFFERED
TABLE 209 BUTTERFLY AYURVEDA PVT. LTD.: BUSINESS OVERVIEW
TABLE 210 BUTTERFLY AYURVEDA PVT. LTD.: PRODUCTS OFFERED
TABLE 211 HERBS NUTRIPRODUCTS PVT. LTD.: BUSINESS OVERVIEW
TABLE 212 HERBS NUTRIPRODUCTS PVT. LTD: PRODUCTS OFFERED
TABLE 213 HERBS NUTRIPRODUCTS PVT. LTD.: OTHERS
TABLE 214 MILLENNIUM HERBAL CARE: BUSINESS OVERVIEW
TABLE 215 MILLENNIUM HERBAL CARE: PRODUCTS OFFERED
TABLE 216 ADJACENT MARKETS TO THE FOOD PROCESSING & HANDLING EQUIPMENT MARKET
TABLE 217 DIETARY SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 218 DIETARY SUPPLEMENTS MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 219 NUTRACEUTICAL PRODUCTS MARKET SIZE, BY TYPE, 2017–2025 (USD BILLION)
TABLE 220 VITAMIN D MARKET SIZE, BY ANALOG, 2016–2019 (USD MILLION)
TABLE 221 VITAMIN D MARKET SIZE, BY TYPE, 2020–2025 (USD MILLION)
TABLE 222 COLLAGEN MARKET SIZE, BY SOURCE, 2019–2026 (USD MILLION)
 
 
LIST OF FIGURES (61 Figures)
 
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION,  AND REGION
FIGURE 4 BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE ESTIMATION,  BY TYPE (SUPPLY-SIDE)
FIGURE 5 MARKET SIZE ESTIMATION  (DEMAND-SIDE)
FIGURE 6 MARKET SIZE ESTIMATION:  BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION:  TOP-DOWN APPROACH
FIGURE 8 DATA TRIANGULATION
FIGURE 9 MARKET SIZE, BY TYPE,  2022 VS. 2027 (USD BILLION)
FIGURE 10 MARKET SIZE, BY FORM,  2022 VS. 2027 (USD BILLION)
FIGURE 11 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD BILLION)
FIGURE 12 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TARGET CONSUMER,  2022 VS. 2027 (USD BILLION)
FIGURE 13 BONE & JOINT HEALTH SUPPLEMENT MARKET SHARE (VALUE), BY REGION, 2021
FIGURE 14 EMERGING ECONOMIES OFFER OPPORTUNITIES FOR MARKET GROWTH
FIGURE 15 VITAMIN D FORMED THE DOMINANT SEGMENT IN TERMS OF TYPE,  IN THE NORTH AMERICAN BONE & JOINT HEALTH SUPPLEMENT MARKET
FIGURE 16 ELDERLY SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 17 NORTH AMERICA LED THE BONE & JOINT HEALTH SUPPLEMENTS MARKET  IN 2021
FIGURE 18 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL BONE &  JOINT HEALTH SUPPLEMENTS MARKET IN 2021
FIGURE 19 POPULATION AGED 65 & ABOVE (% OF TOTAL POPULATION) (2016–2020)
FIGURE 20 DIETARY SUPPLEMENTS MARKET: MARKET DYNAMICS
FIGURE 21 AGING POPULATION IN JAPAN, 2014 - 2021
FIGURE 22 AGING POPULATION IN CHINA, 2014 - 2021
FIGURE 23 AGING POPULATION IN UK, 2014 - 2021
FIGURE 24 AGING POPULATION IN GERMANY, 2014 - 2021
FIGURE 25 PERCENTAGE OF US ADULTS BY AGE TAKING DIETARY SUPPLEMENTS, 2021
FIGURE 26 RETAIL SALE OF NUTRITIONAL AND FORTIFIED PRODUCTS IN AUSTRALIA  (USD MILLION), 2018-2022
FIGURE 27 IMPORT TARIFF OF KEY COUNTRIES ON VITAMINS & VITAMIN SUPPLEMENTS, 2020 (%)
FIGURE 28 NO OF PATENTS GRANTED FOR BONE & JOINT HEALTH SUPPLEMENT MARKET, 2011-2021
FIGURE 29 REGIONAL ANALYSIS OF PATENT GRANTED FOR BONE & JOINT HEALTH SUPPLEMENT MARKET, 2011-2021
FIGURE 30 BONE & HEALTH SUPPLEMENTS: VALUE CHAIN ANALYSIS
FIGURE 31 YC-YCC SHIFT FOR THE BONE & JOINT HEALTH SUPPLEMENTS MARKET
FIGURE 32 BONE & JOINT HEALTH SUPPLEMENT MARKET: MARKET MAP
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE FORMS
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE FORMS
FIGURE 35 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TYPE
FIGURE 36 PRICING ANALYSIS OF KEY PLAYERS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION
FIGURE 37 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY FORM (2017–2021), USD/KG
FIGURE 38 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION (2017–2021), USD/KG
FIGURE 39 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TYPE,  2022 VS 2027 (USD MILLION)
FIGURE 40 BONE & JOINT HEALTH SUPPLEMENT MARKET SHARE, BY FORM,  2022 VS. 2027 (USD MILLION)
FIGURE 41 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TARGET CONSUMER,  2022 VS. 2027 (USD MILLION)
FIGURE 42 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 43 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION,  2022 VS. 2027 (USD MILLION)
FIGURE 44 INDIA IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE GLOBAL MARKET FROM 2022 TO 2027
FIGURE 45 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENT MARKET SNAPSHOT
FIGURE 46 DEATHS BY DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE IN CANADA
FIGURE 47 ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENT MARKET SNAPSHOT
FIGURE 48 JAPAN: COUNTRIES WITH THE LARGEST SHARE OF POPULATION AGED 65 OR OVER, 2019
FIGURE 49 THREE-YEAR TOTAL REVENUE ANALYSIS OF KEY PLAYERS IN THE MARKET,  2019–2021 (USD BILLION)
FIGURE 50 BONE & JOINT HEALTH SUPPLEMENT MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
FIGURE 51 BONE & JOINT HEALTH SUPPLEMENT MARKET: COMPANY EVALUATION QUADRANT, 2021 (OTHER PLAYERS)
FIGURE 52 BAYER: COMPANY SNAPSHOT
FIGURE 53 PROCTER & GAMBLE: COMPANY SNAPSHOT
FIGURE 54 AMWAY: COMPANY SNAPSHOT
FIGURE 55 BASF SE: COMPANY SNAPSHOT
FIGURE 56 ADM: COMPANY SNAPSHOT
FIGURE 57 RECKITT BENCKISER: COMPANY SNAPSHOT
FIGURE 58 PFIZER: COMPANY SNAPSHOT
FIGURE 59 VITA LIFE SCIENCES: COMPANY SNAPSHOT
FIGURE 60 NATURE'S SUNSHINE PRODUCTS, INC.: COMPANY SNAPSHOT
FIGURE 61 GLANBIA PLC: COMPANY SNAPSHOT

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the bone & joint health supplements market. In-depth interviews were conducted with various primary respondents—such as key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants—to obtain and verify critical qualitative and quantitative information as well as to assess prospects. The following figure depicts the research design applied in drafting this report on the market.

Secondary Research

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, gold & silver standard websites, directories, and databases, were referred to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology oriented perspectives

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the bone & joint health supplement market.

TBone & Joint Health Supplements Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the starter cultures market. These methods were also used extensively to estimate the size of the various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues of major starter cultures manufacturers were determined through primary and secondary research, such as paid databases, which were used as the basis for market estimation.
  • All macroeconomic and microeconomic factors affecting the growth of the market were considered while estimating the market size.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using the top-down and bottom-up approaches.

Report Objectives

  • To define, segment, and project the global market for bone & joint health supplements on the basis of type, distribution channel, form, target consumer and region
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and their contribution to the total market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To project the size of the market and its submarkets, in terms of value and volume, with respect to the regions (along with the key countries)
  • To strategically profile the key players and comprehensively analyze their market position and core competencies
  • To analyze the competitive developments such as joint ventures, mergers & acquisitions, new product developments, and research & developments in the bone & joint health supplement market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to the company-specific scientific needs.

  • Further breakdown of the Rest of Europe market for bone & joint health supplements into the The Netherlands, Sweden, Poland, Belgium, Switzerland, and other EU & non-EU countries
  • Further breakdown of the Rest of Asia Pacific market for bone & joint health supplements into Thailand, Indonesia, South Korea, Malaysia, Singapore, Australia, New Zealand, and other ASEAN countries
  • Further breakdown of the Rest of South America market for bone & joint health supplements into Columbia, Peru, Chile, Uruguay, and Venezuela

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Report Code
FB 8121
Published ON
Jun, 2022
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bone & Joint Health Supplements Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved